Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Basic Research in Cardiology
Metadata
Title
Role of cAMP in modulating relaxation kinetics and the force-frequency relation in mitral regurgitation heart failure
Authors
L. A. Mulieri
B. J. Leavitt
R. K. Wright
N. R. Alpert
Publication date
01-01-1997
Publisher
Steinkopff-Verlag
Published in
Basic Research in Cardiology / Issue Special Issue 1/1997
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI
https://doi.org/10.1007/BF00794073

Other articles of this Special Issue 1/1997

Basic Research in Cardiology 1/1997 Go to the issue

OriginalPaper

Expression and function of the cardiac Na+/Ca2+ exchanger in postnatal development of the rat, in experimentaliduced cardiac hypertrophy and in the failing human heart

OriginalPaper

Phosphorylation and regulation of the Ca2+-pumping ATPase in cardiac sarcoplasmic reticulum by calcium/calmodulin-dependent protein kinase

OriginalPaper

Ca transport during contraction and relaxation in mammalian ventricular muscle

OriginalPaper

Plasma membrane calcium pump: structure, function and relationships

OriginalPaper

Molecular and cellular aspects of re-entrant arrhythmias

OriginalPaper

The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits